BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Total Current Assets
BRAIN Biotech AG
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Total Current Assets
€22.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Total Current Assets
€3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Total Current Assets
€5.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Covestro AG
XETRA:1COV
|
Total Current Assets
€6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Total Current Assets
€216.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Total Current Assets
€2.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is BRAIN Biotech AG's Total Current Assets?
Total Current Assets
22.1m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Total Current Assets amounts to 22.1m EUR.
What is BRAIN Biotech AG's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-7%
Over the last year, the Total Current Assets growth was -24%. The average annual Total Current Assets growth rates for BRAIN Biotech AG have been -9% over the past three years , -7% over the past five years .